Vivos in The News Explore The Stories LeadershipFinancial Results & SEC FilingsStock PricingGovernanceNews + Events Menu LeadershipFinancial Results & SEC FilingsStock PricingGovernanceNews + Events Replay the 1st Quarter 2025 Financial Results Conference Call Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET. Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Load More Vivos In The News Closing the Diagnosis Gap for Sleep Apnea with Wearables RNA in Oncology Research, Ultima Genomics Commercially Launches Platform Revolutionizing Sleep Apnea Diagnostics With Home Sleep Testing Solutions
Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide
Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET.
Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
